{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:01:47Z","timestamp":1740124907782,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1038\/s41431-022-01064-3","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T08:02:59Z","timestamp":1646985779000},"page":"1187-1190","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Detection of a pathogenic Alu element insertion in PALB2 gene from targeted NGS diagnostic data"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1911-6698","authenticated-orcid":false,"given":"M\u00e9lanie","family":"Eyries","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Ariste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaelle","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00e9mie","family":"Basset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erell","family":"Guillerm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Duros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odile","family":"Cohen-Haguenauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"de la Grange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Coulet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"1064_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66\u201371.","journal-title":"Science."},{"key":"1064_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789\u201392.","journal-title":"Nature."},{"key":"1064_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylk\u00e4s K, Roberts JK, et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;371:497\u2013506.","journal-title":"N Engl J Med"},{"key":"1064_CR4","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/ng.569","volume":"42","author":"A Meindl","year":"2010","unstructured":"Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet. 2010;42:410\u201314.","journal-title":"Nat Genet"},{"key":"1064_CR5","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/ng.893","volume":"43","author":"C Loveday","year":"2011","unstructured":"Loveday C, Turnbull C, Ramsay E, Hughes D, Ruark E, Frankum JR, et al. Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat Genet. 2011;43:879\u201382.","journal-title":"Nat Genet"},{"key":"1064_CR6","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.bulcan.2018.08.003","volume":"105","author":"J Moretta","year":"2018","unstructured":"Moretta J, Berthet P, Bonadona V, Caron O, Cohen-Haguenauer O, Colas C. et al. The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition. Bull Cancer. 2018;105:907\u201317.","journal-title":"Bull Cancer"},{"key":"1064_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1056\/NEJMra1510092","volume":"377","author":"HH Kazazian","year":"2017","unstructured":"Kazazian HH, Moran JV. Mobile DNA in health and disease. N Engl J Med. 2017;377:361\u201370.","journal-title":"N Engl J Med"},{"key":"1064_CR8","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1200\/JCO.2006.06.9443","volume":"25","author":"PM Machado","year":"2007","unstructured":"Machado PM, Brand\u00e3o RD, Cavaco BM, Eug\u00e9nio J, Bento S, Nave M, et al. Screening for a BRCA2 rearrangement in high-risk breast\/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes. J Clin Oncol. 2007;25:2027\u201334.","journal-title":"J Clin Oncol"},{"key":"1064_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13100-016-0065-9","volume":"7","author":"DC Hancks","year":"2016","unstructured":"Hancks DC, Kazazian HH. Roles for retrotransposon insertions in human disease. Mob DNA. 2016;7:9.","journal-title":"Mob DNA."},{"key":"1064_CR10","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41431-018-0207-2","volume":"11","author":"S Baert-Desurmont","year":"2018","unstructured":"Baert-Desurmont S, Coutant S, Charbonnier F, Macquere P, Lecoquierre F, Schwartz M, et al. Optimization of the diagnosis of inherited colorectal cancer using NGS and capture of exonic and intronic sequences of panel genes. Eur J Hum Genet. 2018;11:1597\u2013602.","journal-title":"Eur J Hum Genet"},{"key":"1064_CR11","first-page":"405","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med J Am Coll Med Genet. 2015;17:405\u201324.","journal-title":"Genet Med J Am Coll Med Genet"},{"key":"1064_CR12","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.ajhg.2016.03.024","volume":"98","author":"LM Amendola","year":"2016","unstructured":"Amendola LM, Jarvik GP, Leo MC, McLaughlin HM, Akkari Y, Amaral MD, et al. Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the Clinical Sequencing Exploratory Research Consortium. Am J Hum Genet. 2016;98:1067\u201376.","journal-title":"Am J Hum Genet"},{"key":"1064_CR13","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jmoldx.2017.08.002","volume":"6","author":"CM Watson","year":"2017","unstructured":"Watson CM, Camm N, Crinnion LA, Antanaviciute A, Adlard J, Markham AF, et al. Characterization and genomic localization of a SMAD4 processed pseudogene. J Mol Diagn. 2017;6:933\u201340.","journal-title":"J Mol Diagn"},{"key":"1064_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.molcel.2006.05.022","volume":"22","author":"B Xia","year":"2006","unstructured":"Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu J, Christ N, et al. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell. 2006;22:719\u201329.","journal-title":"Mol Cell"},{"key":"1064_CR15","doi-asserted-by":"publisher","first-page":"18302","DOI":"10.1074\/jbc.M109.016717","volume":"284","author":"SM-H Sy","year":"2009","unstructured":"Sy SM-H, Huen MSY, Zhu Y, Chen J. PALB2 regulates recombinational repair through chromatin association and oligomerization. J Biol Chem. 2009;284:18302\u201310.","journal-title":"J Biol Chem."},{"key":"1064_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/ng1942","volume":"39","author":"B Xia","year":"2007","unstructured":"Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, Sheng Q. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet. 2007;39:159\u201361.","journal-title":"Nat Genet"},{"key":"1064_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ng1959","volume":"39","author":"N Rahman","year":"2007","unstructured":"Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet. 2007;39:165\u20137.","journal-title":"Nat Genet"},{"key":"1064_CR18","first-page":"683","volume":"21","author":"ME Richardson","year":"2019","unstructured":"Richardson ME, Chong H, Mu W, Conner BR, Hsuan V, Willett S, et al. DNA breakpoint assay reveals a majority of gross duplications occur in tandem reducing VUS classifications in breast cancer predisposition genes. Genet Med J Am Coll Med Genet. 2019;21:683\u201393.","journal-title":"Genet Med J Am Coll Med Genet"},{"key":"1064_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10549-016-4021-7","volume":"160","author":"C Yang","year":"2016","unstructured":"Yang C, Arnold AG, Trottier M, Sonoda Y, Abu-Rustum NR, Zivanovic O, et al. Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family. Breast Cancer Res Treat. 2016;160:447\u201356.","journal-title":"Breast Cancer Res Treat"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01064-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01064-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01064-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T14:04:37Z","timestamp":1665497077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01064-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1064"],"URL":"https:\/\/doi.org\/10.1038\/s41431-022-01064-3","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"type":"print","value":"1018-4813"},{"type":"electronic","value":"1476-5438"}],"subject":[],"published":{"date-parts":[[2022,3,11]]},"assertion":[{"value":"27 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All patients gave their informed consent for genetic research, which was approved by the \u201cComit\u00e9 de Protection des Personnes Ile de France-VI\u201d, decision ID RCB2007-AO1347-46.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}